Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Eli Lilly

Eli Lilly

Rank: 14

Indianapolis, USA
www.lilly.com

2020 Revenues ($USD) : $24,539,800,000
2020 R&D spend : $6,086,000,000
2020 Number of Employees : 35,000
Fiscal Year End : 12/31/2020
Key People : David A. Ricks, chairman and CEO; Anat Ashkenazi, senior vice president and chief financial officer; Melissa Stapleton Barnes, Senior Vice President, Enterprise Risk Management, and Chief Ethics and Compliance Officer; Stephen F. Fry, Senior Vice President, Human Resources and Diversity; Anat Hakim, Senior Vice President, General Counsel and Secretary; Patrik Jonsson, Senior Vice President; President, Lilly USA; and Chief Customer Officer; Michael B. Mason, Senior Vice President and President, Lilly Diabetes; Johna L. Norton, Senior Vice President, Global Quality; Myles O'Neill, Senior Vice President and President, Manufacturing Operations; Leigh Ann Pusey, Senior Vice President, Corporate Affairs and Communications; Aarti Shah, Senior Vice President and Chief Information and Digital Officer; Dr. Daniel M. Skovronsky, Senior Vice President and Chief Scientific Officer; Anne E. White, Senior Vice President and President, Lilly Oncology; Ilya Yuffa, Senior Vice President and President, Lilly Bio-Medicines; Alfonso Zulueta, Senior Vice President and President, Lilly International

Eli Lilly was founded in 1876 and has 24 drugs that it currently manufactures and distributes in 120 countries. The Indianapolis-based company makes drugs for diabetes, oncology, immunology, neurosciences and other therapies, including COVID-19 treatment therapies. Eli Lilly picked up two companies in the last year. It bought Prevail Therapeutics for $880 million in January this year and Disarm Therapeutics for $135 million in October 2020. Last year, Eli Lilly won FDA approval for a couple of its drugs, including additional doses of its Trulicity drug to treat type 2 diabetes, Cyramza for treating metastatic EGFR-mutated non-small cell lung cancer and Tauvid for patients evaluated for Alzheimer's disease. –DK

Lilly

An Eli Lilly technician oversees a step in Baricitinib manufacturing. Baricitinib is a treatment of rheumatoid arthritis.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50